Skip to main
BLFS
BLFS logo

BioLife Solutions (BLFS) Stock Forecast & Price Target

BioLife Solutions (BLFS) Analyst Ratings

Based on 13 analyst ratings
Strong Buy
Strong Buy 62%
Buy 38%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

BioLife Solutions Inc. has demonstrated solid financial performance, with Cell Processing revenue growing 12% year-over-year to $73.5 million in 2024 and a sequential increase of 7% to $20.3 million in the fourth quarter of 2024. The company has raised its FY24 guidance for Cell Processing, now estimating revenue between $72 million and $73 million, and projecting continued robust growth into FY25, with anticipated revenue between $82 million and $85 million, representing a 15% year-over-year increase. Additionally, increased demand for its biopreservation media, coupled with strategic divestitures enhancing gross margins, positions the company for strong long-term growth, with management expecting gross margins in the low 60% range and total revenue for 2025 projected at $95.5 million to $99 million, reflecting a 16-20% year-over-year growth outlook.

Bears say

BioLife Solutions Inc. faces multiple risks that contribute to a negative outlook, including the potential for lower-than-projected growth in its bioproduction products and services, as well as challenges in securing additional customers. The company reported a net loss of $11.4 million, equating to a loss of $0.25 per share, which raises concerns about its financial sustainability. Additionally, risks associated with fluctuations in sales in emerging markets, foreign exchange rates, and manufacturing or supply chain disruptions further exacerbate uncertainties surrounding its revenue generation and operational stability.

BioLife Solutions (BLFS) has been analyzed by 13 analysts, with a consensus rating of Strong Buy. 62% of analysts recommend a Strong Buy, 38% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of BioLife Solutions and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About BioLife Solutions (BLFS) Forecast

Analysts have given BioLife Solutions (BLFS) a Strong Buy based on their latest research and market trends.

According to 13 analysts, BioLife Solutions (BLFS) has a Strong Buy consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $27.54, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $27.54, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

BioLife Solutions (BLFS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.